NGEN earnings: next report 2026-08-21, real EPS beat/miss history, analyst consensus Buy, P/E -8.41. Updated 2026-07-23.
NervGen Pharma Corp. Common stock (NGEN) Research Hub
NervGen Pharma Corp. Common stock (NGEN) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.185 USD (+2.58%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -8.41, market cap 0.14B. This hub links to the full technical, earnings and options research available for NGEN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 2.185 USD (+2.58%) |
| 52-week range | 1.58 USD – 2.4 USD |
| Trend regime | Range |
| 14-day RSI | 72.9 (Overbought) |
| Trailing P/E | -8.41 |
| Market cap | 0.14B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-21 |
Available research for NGEN
Covered Call on NGEN: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NGEN: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NGEN: how it works, illustrative setup around the real 2.19 USD price, max profit/loss, breakeven and when to use it. Educational.
NGEN technical analysis: range, last 2.185 USD, RSI 72.9, 52w range 1.58 USD–2.4 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NGEN in?
NervGen Pharma Corp. Common stock (NGEN) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is NGEN in an uptrend or downtrend?
As of 2026-09-11, NGEN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NGEN's trailing P/E ratio?
NGEN's trailing P/E is -8.41, with a market cap of 0.14B. See the earnings research page for full valuation detail.
When does NGEN next report earnings?
NGEN is next scheduled to report earnings on 2026-08-21, with a consensus EPS estimate of -0.09 USD.